Literature DB >> 8431015

High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases.

J Gilbart1, C R Perry, B Slocombe.   

Abstract

Mupirocin resistance in Staphylococcus aureus results from changes in the target enzyme, isoleucyl-tRNA synthetase (IRS). Twelve strains of S. aureus comprising four susceptible (MICs < or = 4 micrograms/ml), four intermediate level-resistant (MICs between 8 and 256 micrograms/ml), and four highly resistant (MICs > or = 512 micrograms/ml) isolates were examined for their IRS content and the presence of a gene known to encode high-level mupirocin resistance. Ion-exchange chromatography of cell extracts showed a single IRS active peak in mupirocin-susceptible strains, with 50% inhibitory concentrations (IC50s) of 0.7 to 3.0 ng of mupirocin per ml. In strains showing intermediate mupirocin resistance, similar single IRS activity peaks were observed, but these were less sensitive to inhibition, and the mupirocin IC50s for them were 19 to 43 ng/ml. Strains that were highly resistant to mupirocin displayed two distinct peaks; one was similar to that found with susceptible strains (IC50, 0.9 to 2.5 ng/ml), but an additional peak with an IC50 of 7,000 to 10,000 ng/ml was also observed. A strain cured of the plasmid encoding high-level mupirocin resistance lacked the resistant IRS peak. Restriction digests, produced by endonuclease NcoI, of total bacterial DNA isolated from the highly resistant strains hybridized with a mupirocin resistance gene probe, whereas DNA isolated from the intermediate level-resistant and susceptible strains did not. These results demonstrate that two different IRS enzymes were present in highly mupirocin-resistant S. aureus strains. In strains expressing intermediate levels of resistance, only a chromosomally encoded IRS which was inhibited less by mupirocin than IRS from fully susceptible strains was detected.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8431015      PMCID: PMC187600          DOI: 10.1128/AAC.37.1.32

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Mupirocin-resistant Staphylococcus aureus.

Authors:  B D Cookson; R W Lacey; W C Noble; D S Reeves; R Wise; R J Redhead
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

3.  Ribosomal ribonucleic acid gene restriction patterns as potential taxonomic tools.

Authors:  F Grimont; P A Grimont
Journal:  Ann Inst Pasteur Microbiol       Date:  1986 Sep-Oct

4.  Mupirocin-resistant Staphylococcus aureus.

Authors: 
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

Review 5.  The antimicrobial activity of mupirocin--an update on resistance.

Authors:  B Slocombe; C Perry
Journal:  J Hosp Infect       Date:  1991-09       Impact factor: 3.926

6.  Staphylococcus aureus resistant to mupirocin.

Authors:  G E Smith; C T Kennedy
Journal:  J Antimicrob Chemother       Date:  1988-01       Impact factor: 5.790

7.  Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase.

Authors:  J Hughes; G Mellows
Journal:  Biochem J       Date:  1980-10-01       Impact factor: 3.857

8.  In-vitro activity of mupirocin ('pseudomonic acid') against clinical isolates of Staphylococcus aureus.

Authors:  M W Casewell; R L Hill
Journal:  J Antimicrob Chemother       Date:  1985-05       Impact factor: 5.790

9.  Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use.

Authors:  R Sutherland; R J Boon; K E Griffin; P J Masters; B Slocombe; A R White
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

10.  Mechanism of mupirocin transport into sensitive and resistant bacteria.

Authors:  J O Capobianco; C C Doran; R C Goldman
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

View more
  45 in total

Review 1.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Bacillus subtilis functional genomics: global characterization of the stringent response by proteome and transcriptome analysis.

Authors:  Christine Eymann; Georg Homuth; Christian Scharf; Michael Hecker
Journal:  J Bacteriol       Date:  2002-05       Impact factor: 3.490

3.  Isoleucyl-tRNA synthetase mutations in Staphylococcus aureus clinical isolates and in vitro selection of low-level mupirocin-resistant strains.

Authors:  Shigeru Fujimura; Yutaka Tokue; Akira Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

4.  A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions.

Authors:  Elaine S Walker; Foster Levy; Mahmoud Shorman; Gerard David; Jehad Abdalla; Felix A Sarubbi
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

Review 5.  Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

6.  High-level mupirocin resistance within methicillin-resistant Staphylococcus aureus pandemic lineages.

Authors:  Eduardo Pérez-Roth; Celeste López-Aguilar; Julia Alcoba-Florez; Sebastián Méndez-Alvarez
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

7.  Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children.

Authors:  J Chase McNeil; Kristina G Hulten; Sheldon L Kaplan; Edward O Mason
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

8.  Mupirocin - Are we in danger of losing it?

Authors:  John M Conly; B Lynn Johnston
Journal:  Can J Infect Dis       Date:  2002-05

9.  Enzymatic glycosylation of the topical antibiotic mupirocin.

Authors:  Prakash Parajuli; Ramesh Prasad Pandey; Anaya Raj Pokhrel; Gopal Prasad Ghimire; Jae Kyung Sohng
Journal:  Glycoconj J       Date:  2014-07-30       Impact factor: 2.916

10.  In vitro activity of mupirocin against methicillin-resistant Staphylococcus aureus isolated from a hospital in Spain.

Authors:  T Alarcón; D Domingo; M C del Rey; S López; I Sánchez; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.